my account  log out
 

Product Name:Celecoxib

Create: 04/17/2018
Expired Date:never
Category: Methacrylate intermediates [Chemical]
Message:Product Name:Celecoxib Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis
City:Wuhan Hubei[CN] 
Location:
 
Jun 19 2018 Flunixin meglumin66666503
Jun 19 2018 Flunixin meglumin2222515
Jun 19 2018 Flunixin meglumin5553223489
Jun 19 2018 Flunixin meglumin565652527
Jun 19 2018 Flunixin meglumin535552521
Jun 19 2018 Flunixin meglumin565623523
Jun 19 2018 Flunixin meglumin52222517
Jun 19 2018 Flunixin meglumin5252543
Jun 19 2018 Flunixin meglumin4574564521
Jun 19 2018 Flunixin meglumin56+56565550

return back

Copyright © toextrade Inc. All rights reserved. Contact us